Light Mode
$0.0001 ↑ +0.0000 (+0.00%) Trading Up from the previous close of $0.0001, and at the day’s high of $0.0001
-0.00 (-95.00%) / 6M
Momentum, market sentiment, and recent alerts
GBLX reads n/a: price sits below both the 20- and 200-day averages, the 12-month move is -66.7%.
No alerts for GBLX in the last day.
Earnings, valuation, and balance sheet
Company profile and competitor comparison
GB Sciences, Inc. is a biopharmaceutical research and development company, which engages in creating patented, disease-targeted formulations of cannabis, and other plant-inspired therapeutic mixtures for the prescription drug market through its Canadian subsidiary, GbS Global Biopharma, Inc. The company was founded on April 4, 2001, and is headquartered in Las Vegas, NV.
Real-time scanning and AI-generated signals across the entire market.
Prices and alerts are delayed by at least 20 minutes. Chart history reflects daily closing prices. Information is provided for research purposes only and is not investment advice.